HUP9900895A2 - Simaizom sejtburjánzást gátló 2-szubsztituált benzimidazolszármazékok - Google Patents

Simaizom sejtburjánzást gátló 2-szubsztituált benzimidazolszármazékok

Info

Publication number
HUP9900895A2
HUP9900895A2 HU9900895A HUP9900895A HUP9900895A2 HU P9900895 A2 HUP9900895 A2 HU P9900895A2 HU 9900895 A HU9900895 A HU 9900895A HU P9900895 A HUP9900895 A HU P9900895A HU P9900895 A2 HUP9900895 A2 HU P9900895A2
Authority
HU
Hungary
Prior art keywords
cell proliferation
smooth muscle
muscle cell
proliferation inhibitors
compounds
Prior art date
Application number
HU9900895A
Other languages
English (en)
Inventor
Hassan Mahmoud Elokdah
Chai Sie-Yearl
Theodore Sylvester Sulkowski
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of HUP9900895A2 publication Critical patent/HUP9900895A2/hu
Publication of HUP9900895A3 publication Critical patent/HUP9900895A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10Radicals substituted by halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A találmány tárgy (I) általánős képletű vegyületek, ahől R1 jelentéseprőpil-, triflűőr-metil- vagy piridin-2-il-csőpőrt; R2 jelentéseszűbsztitűált benzilcsőpőrt, ahől a szűbsztitűensek egymástólfüggetlenül lehetnek 1 vagy 2 halőgénatőm, karbőxil- vagy 2-7szénatőmős alkőxi-karbőnilcsőpőrt; R3 és R4 jelentése hidrőgénatőm,metil- vagy nitrőcsőpőrt; azzal a megkötéssel, hőgy ha R1 piridin-2-il- vagy prőpilcsőpőrt és R3 és R4 hidrőgénatőm, akkőr R2 para-klór-benzilcsőpőrttól eltérő, tővábbá azzal a megkötéssel, hőgy ha R1prőpilcsőpőrt, akkőr R2 nem lehet karbőxil- vagy alkőxi-karbőnilcsőpőrttal szűbsztitűálva, valamint a vegyületeket tartalmazógyógyászati készítmények, melyeket simaizőm- sejtbűrjánzásinhibitőrőkként használhatnak. A találmány kiterjed a vegyületekettartalmazó gyógyászati készítményekre és a vegyületek előállításárais. ŕ
HU9900895A 1995-06-07 1996-06-03 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors HUP9900895A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/477,842 US5654436A (en) 1995-06-07 1995-06-07 2-substituted benzimidazole derivatives

Publications (2)

Publication Number Publication Date
HUP9900895A2 true HUP9900895A2 (hu) 1999-07-28
HUP9900895A3 HUP9900895A3 (en) 2001-08-28

Family

ID=23897571

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900895A HUP9900895A3 (en) 1995-06-07 1996-06-03 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors

Country Status (18)

Country Link
US (1) US5654436A (hu)
EP (1) EP0830344B1 (hu)
JP (1) JPH11506752A (hu)
KR (1) KR19990022318A (hu)
CN (1) CN1192204A (hu)
AR (1) AR003129A1 (hu)
AT (1) ATE209635T1 (hu)
BR (1) BR9608557A (hu)
CA (1) CA2223962A1 (hu)
DE (1) DE69617420T2 (hu)
ES (1) ES2165501T3 (hu)
HU (1) HUP9900895A3 (hu)
IL (1) IL118412A0 (hu)
NZ (1) NZ309498A (hu)
PT (1) PT830344E (hu)
TW (1) TW322473B (hu)
WO (1) WO1996040644A1 (hu)
ZA (1) ZA964622B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990146A (en) * 1997-08-20 1999-11-23 Warner-Lambert Company Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
US8163777B2 (en) 2006-03-23 2012-04-24 Synta Pharmaceuticals Corp. Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
US8501957B2 (en) * 2008-12-10 2013-08-06 China Medical University Benzimidazole compounds and their use as anticancer agents
JP6212628B2 (ja) * 2013-04-29 2017-10-11 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 2−フェニル又は2−ヘタリールイミダゾール[1,2−a]ピリジン誘導体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2876233A (en) * 1956-10-29 1959-03-03 Gruenenthal Chemie 1-(p-halobenzyl)-2-methyl benzimidazoles and salts
FR1228524A (hu) * 1958-05-23 1960-08-31
FR1530439A (fr) * 1966-05-16 1968-06-28 Pentachlorobenzyl-1 benzimidazoles
HU193951B (en) * 1985-03-11 1987-12-28 Richter Gedeon Vegyeszet Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
US5128359A (en) * 1990-02-16 1992-07-07 Laboratoires Upsa Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation
GB9027200D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
DE4212748A1 (de) * 1992-04-16 1993-10-21 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5387600A (en) * 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions

Also Published As

Publication number Publication date
BR9608557A (pt) 1999-07-06
KR19990022318A (ko) 1999-03-25
AU5968396A (en) 1996-12-30
NZ309498A (en) 2000-09-29
TW322473B (hu) 1997-12-11
JPH11506752A (ja) 1999-06-15
DE69617420D1 (de) 2002-01-10
CA2223962A1 (en) 1996-12-19
EP0830344B1 (en) 2001-11-28
AR003129A1 (es) 1998-07-08
WO1996040644A1 (en) 1996-12-19
IL118412A0 (en) 1996-09-12
EP0830344A1 (en) 1998-03-25
ES2165501T3 (es) 2002-03-16
AU697295B2 (en) 1998-10-01
CN1192204A (zh) 1998-09-02
MX9709650A (es) 1998-07-31
DE69617420T2 (de) 2002-05-02
ATE209635T1 (de) 2001-12-15
PT830344E (pt) 2002-04-29
ZA964622B (en) 1997-12-04
HUP9900895A3 (en) 2001-08-28
US5654436A (en) 1997-08-05

Similar Documents

Publication Publication Date Title
HUP0002112A2 (hu) Helyettesített 3-ciano-kinolinok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
HUP0302943A2 (hu) Új heterociklusos vegyületek, előállításuk és alkalmazásuk gyógyszerekként, különösen antibakteriális szerekként
RU95108387A (ru) Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина
BG106073A (en) Quinoline derivatives as inhibitors of mek enzymes
HUP0303756A2 (hu) 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények
ES8401031A1 (es) Una tetrahidroftalimida.
HUP9901613A2 (hu) Szubsztituált tetraciklusos kondenzált furán-amin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
MY117783A (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
ES8203845A1 (es) Procedimiento para preparar derivados de piridoxina
DE3876813D1 (de) 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
HUP0000980A2 (hu) Akril-nitril-vegyületek, eljárás előállításukra, valamint akril-nitril- vegyületeket tartalmazó peszticidek
ATE64733T1 (de) ((2,3,9,9a-tetrahydro-3-oxo-9a-substituierte-1h fluoren-7-yl)-oxy>ethanimidamide und ((2,3,9,9atetrahydro-3-oxo-9a-substituierte-1h-fluoren-7- yl)-oxy>ethanimidsaure hydrazide, ihre derivate und salze.
HUP9903758A2 (hu) Benzoxazinon dopamin D4 receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények
IT1315267B1 (it) Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
ES482700A1 (es) Procedimiento para la obtencion de alfa-azolil-beta-hidroxi-cetonas.
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
NZ332923A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
NO995638L (no) Heterobicykliske forbindelser til fremstilling av pyridonkarboksylsyrederivater
HUP9702393A2 (hu) bisz(2-Halogén-etil)-amino-fenil szubsztituált distamycinszármazékok, tumorellenes és vírusellenes hatóanyagok
RU1833371C (ru) Cпocoб пoлучehия amидoпpoизboдhыx 4-фehил-3-буtehoboй kиcлotы
SE9102909L (sv) Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)
ES2008962A6 (es) Proceso para la preparacion de nuevos compuestos de 2-guanidinotiazol
TR200103009T2 (tr) Yeni aromatik amidlerin hazırlanma yöntemleri ve ilaç olarak kullanımları
HUP9900895A2 (hu) Simaizom sejtburjánzást gátló 2-szubsztituált benzimidazolszármazékok